Type
PUPO. [How to obtain complete security by eradicating leprosy in the State of São Paulo]. Revista brasileira de medicina. 1955;12(12):868-70.
Type
QUAGLIATO. [Problem of relapses in our leprosy dispensaries]. Revista brasileira de leprologia. 1955;23(1-4):83-113.
Type
ROTBERG. [Review of the lepromin reaction and immunity to leprosy, 1933-1953]. Revista brasileira de leprologia. 1955;23(1-4):1-22.
Type
van Brakel WH, De Soldenhoff, McDougall. The allocation of leprosy patients into paucibacillary and multibacillary groups for multidrug therapy, taking into account the number of body areas affected by skin, or skin and nerve lesions. Leprosy review [Internet]. 1992;63(3):231-46. Available from: http://leprev.ilsl.br/pdfs/1992/v63n3/pdf/v63n3a05.pdf
Type
Wang, Liu, Jeng, Lin, Hsieh, Chuang, et al. Autoantibodies and related immunity of leprosy patients from leprosarium in Taiwan. Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology. 1992;25(3):181-8.
Type
Ponnighaus, Fine PE, Sterne, Wilson, Msosa, Gruer, et al. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet (London, England). 1992;339(8794):636-9.
Type
Bettering BCG. Lancet (London, England). 1992;339(8791):462-3.
Type
Convit, Sampson, Zuniga, Smith, Plata, Silva, et al. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet (London, England). 1992;339(8791):446-50.
Type
Arvelo. [Basic concepts in the rehabilitation of leprosy patients]. Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau. 1976;81(4):355-62.
Type
SUMMERS, ZIMMERMAN. Tuberculoid leprosy. Neurology. 1957;7(11):798-802.